Trinity Capital Commits $20 Million to ABM Respiratory Care

Trinity Capital Inc. has committed $20 million in growth capital to ABM Respiratory Care, a financing intended to support the medical technology company’s commercial expansion, product development and clinical research.

ABM develops airway clearance and ventilation technologies for hospitals and home care. Its BiWaze platform includes systems designed for use in those settings. The financing is also intended to help ABM expand its reach in global markets.

The commitment follows a quarter in which Trinity recorded $880 million in new commitments and funded $614 million in gross investments across 39 portfolio companies. Of the $614 million invested, Trinity allocated $378 million to secured loans, $159 million to equipment financing, and $77 million to equity and warrants. Trinity’s new commitments totaled $2 billion through the first three quarters of 2026.